The price of INO is predicted to go up 1.97%, based on the high correlation periods with WM. The similarity of these two price pattern on the periods is 90.67%.
INO
WM
Up: 1.97%Similarity: 90.67%
INO Revenue Forecast
INO EPS Forecast
INO FAQs
What is INO revenue forecast for next quarter?
The market consensus for INO's revenue in the upcoming quarter is projected to be approximately $50K USD.
Oppenheimer lowered the firm's price target on Inovio to $15 from $33 and keeps an Outperform rating on the shares after the company reported Q3 financial updates and business highlights, including progress on BLA filing for INO-3107 planned for mid-2025. The firm notes that total Q3 OpEx was $27.3M, resulting in $84.8M of cash providing financial runway through Q3 2025 to support BLA submission. Oppenheimer was also encouraged by regulatory progress ex-U.S. and new immunology data that supports the biological basis for INO-3107's clinical benefit.